富祥药业(300497.SZ)：通过巴西国家卫生监督局GMP认证

Core Viewpoint - Fuxiang Pharmaceutical has obtained the GMP certification from Brazil's National Health Surveillance Agency (ANVISA) for its chemical raw material, Tazobactam, enabling the company to enter the Brazilian market and expand its international presence [1] Group 1 - The certification scope includes the chemical raw material drug Tazobactam [1] - Brazil is the largest country in South America, making this certification significant for market entry [1] - The successful certification lays a solid foundation for further expansion into the Brazilian market and other international markets, enhancing the company's global competitiveness [1]